$MDLZ

MDLZ Looks 14.5% Undervalued on GF Value™ as Dividend Sustainabi

Mondelez International (MDLZ) launched Clif High Protein bars, entering the high-protein snack market. The company offers a 3.09% dividend yield, a 64% payout ratio, and a 9.7% 3-year dividend growth rate. MDLZ is modestly undervalued with a GF Value™ of $75.69 vs. current price of $64.70. Insiders have sold $8.7M in shares over the past year, while 14 premium gurus hold positions in the stock.

Original reporting
Published Aug 25, 2026, 1:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 1:23 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$MDLZ
Bullish
medium confidence
Mentioned
$MDLZ
Relevance
6/10
alphai data visualization · based on gurufocus.com
Decision brief

The 30-second read

$MDLZBullishLow
01

Why it matters

The high‑protein bar launch is a strategic diversification aimed at capturing growth in the health‑focused snack market.

02

Market read

The announcement provides a modest catalyst for MDLZ, primarily of interest to dividend‑focused investors.

03

What to watch

Current low current ratio and debt levels could constrain marketing spend for the new product.

Relevance 6/10Novelty 6/10Timing: announced today

Background

Mondelez International (MDLZ) is a leading consumer defensive company known for snacks like Oreo and Chips Ahoy.

Company-level read

Ticker impact

$MDLZBullishMedium confidence
Context

Mondelez announced the launch of Clif High Protein bars, entering the high‑protein snack market.

Expected impact

Modest upside potential if the snack line gains market share.

Evidence & confidence

Launch is a fresh corporate development but scale is limited; impact depends on consumer adoption.

Market effects

Adds competitive pressure in the consumer defensive snack segment.

Potentially strengthens Mondelez's presence in North America and developed markets.

Limited global impact; primarily relevant to snack investors.

Counterpoint

Insider selling and modest liquidity may signal concerns about the launch's profitability.

Key entities

  • Mondelez International Inc

    Issuer of the new high‑protein snack line.

Related articles

$MDLZMedAI 8/10

MDLZ Q2 Sales Beat and Higher 2026 Growth View Put Margins in Focus

Mondelez (MDLZ) reported Q2 net revenue of $9.36B (+4.1% YoY), beating estimates. Adjusted EPS of $0.73 also beat. Organic net revenue grew 2.2%. MDLZ raised its 2026 organic net revenue growth outlook to at least 2%. Operating income declined 6.1% due to higher costs. Management maintained 2026 adjusted EPS growth guidance of flat to 5%.

$MDLZMed

Can Mondelez's Organic Growth Momentum Continue Through 2026?

Mondelez (MDLZ) reported 2.2% organic revenue growth in Q2 2026, driven by volume/mix and pricing. The company raised its full-year outlook to at least 2% growth. Emerging Markets and North America showed strong performance, while Europe lagged due to weather impacts. Shares have risen 15.5% year-to-date, outperforming the industry.

$MDLZMed

Mondelez International, Inc. Q2 2026 Earnings Call Summary

Strategic Performance Drivers Emerging markets delivered robust 4.4% top-line growth, driven by structural distribution expansion rather than cyclical trends, with India and Brazil reaching significant store milestones. North American performance is characterized by a 'K-shaped' recovery where consumers are simultaneously seeking value formats and premium 'better-for-you' options.

$MDLZMed

Is Wall Street Bullish or Bearish on Mondelez International Stock?

Mondelez International (MDLZ) has lagged the S&P 500 over 52 weeks, down 3.8% versus SPX up 16.5%, though YTD it is up 16.4%. The company cited cocoa cost inflation and North America volume weakness. After Q2 2026 results, it rose over 4% on adjusted EPS of $0.73 and revenue of $9.36B, raising FY organic net revenue growth to at least 2%. Analysts expect 2026 adjusted EPS of $3.04. BTIG raised its price target to $73.

$MDLZMedAI 8/10

Mondelez beats second-quarter estimates on steady demand

Mondelez International reported Q2 adjusted profit of 68 cents, beating the 68-cent consensus, and quarterly net revenue of $9.36B versus a $9.20B estimate, helped by steady demand and higher pricing. It raised its annual organic net revenue growth outlook to at least 2%. North America pricing rose 2.2 points; volumes rose 1.2.